Amgen seeks FDA approval for monthly dosing option for Repatha

September 11, 2015 2:03 PM

31 0

Amgen seeks FDA approval for monthly dosing option for Repatha

Amgen Inc said it had asked the U.S. Food and Drug Administration to approve a monthly single-dosing option for its recently approved cholesterol drug, Repatha.

The FDA approved Repatha, one of two approved treatments in a new class of injectable "bad" cholesterol-lowering drugs called PCSK9 inhibitors, on Aug. 27.

Also read: FDA approves new drug to treat Parkinson's disease

Read more

To category page

Loading...